Clinical Trial Update: Optivate in People With Von Willebrand Disease Undergoing Surgery [Phase 3]

View source ↗

Summary

Phase 3 trial of Optivate for von Willebrand disease in patients undergoing surgery has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Von Willebrand Disease

Drugs mentioned

• Optivate (von Willebrand factor concentrate (plasma-derived))

Snippet

Sponsor: Bio Products Laboratory | Conditions: Von Willebrand Disease | Phase 3 | Status: TERMINATED